Dr. Muzaffar Qazilbash, MD
Claim this profileM D Anderson Cancer Center
Area of expertise
Multiple Myeloma
Muzaffar Qazilbash, MD has run 4 trials for Multiple Myeloma. Some of their research focus areas include:
Plasma Cell Neoplasm
Muzaffar Qazilbash, MD has run 1 trial for Plasma Cell Neoplasm. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Muzaffar Qazilbash, MD is currently running
Engineered NK Cell Therapy
for Multiple Myeloma
To find the recommended dose of NY-ESO-1 TCR/IL-15 NK cells that can be given to patients with relapsed or refractory MM. To learn if the dose of NY-ESO-1 TCR/IL-15 NK cells found in Part A can help to control the disease.
Recruiting
1 award
Phase 1 & 2
23 criteria
Isatuximab + Lenalidomide
for Multiple Myeloma
To learn if isatuximab can help to control highrisk MM when given in combination with lenalidomide after an autologous stem cell transplantation (ASCT).
Recruiting
1 award
Phase 2
12 criteria
More about Muzaffar Qazilbash, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Muzaffar Qazilbash, MD has experience with
- Lenalidomide
- Daratumumab
- Cyclophosphamide
- Fludarabine Phosphate
- NY-ESO-1 TCR/IL-15 NK Cells
- Isatuximab
Breakdown of trials Muzaffar Qazilbash, MD has run
Multiple Myeloma
Plasma Cell Neoplasm
Lymphoma
Mixed-Cell Lymphoma
Central Nervous System Hodgkin Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Muzaffar Qazilbash, MD specialize in?
Muzaffar Qazilbash, MD focuses on Multiple Myeloma and Plasma Cell Neoplasm. In particular, much of their work with Multiple Myeloma has involved NY-ESO-1 positive patients, or patients who are HLA-A positive.
Is Muzaffar Qazilbash, MD currently recruiting for clinical trials?
Yes, Muzaffar Qazilbash, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Muzaffar Qazilbash, MD has studied deeply?
Yes, Muzaffar Qazilbash, MD has studied treatments such as Lenalidomide, Daratumumab, Cyclophosphamide.
What is the best way to schedule an appointment with Muzaffar Qazilbash, MD?
Apply for one of the trials that Muzaffar Qazilbash, MD is conducting.
What is the office address of Muzaffar Qazilbash, MD?
The office of Muzaffar Qazilbash, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.